Back to Blog

Navigating Minor Cannabinoids: CBN, CBG, THCv, and CBC

Topic: Patient Information

When most people think about cannabis, they often know about the two main cannabinoids: THC and CBD. But cannabis is a complex plant with many other cannabinoids, each with its own unique effects. THCv, CBC, CBG, and CBN are lesser known “minor cannabinoids” that are becoming more present in the medical and recreational markets. Navigating between them all might seem tricky at first, but we have a few tips for making it easy.

What Are Cannabinoids?

Cannabinoids are natural compounds found in cannabis plants. These compounds interact with your body’s endocannabinoid system, which may impact things like mood, appetite, pain, and sleep. While THC and CBD are the most well-known cannabinoids, there are many others that may offer different benefits. Let’s take a closer look at some of these minor cannabinoids.

CBN (Cannabinol)

What is CBN? CBN is what THC turns into when it ages. It’s not as psychoactive as THC but may help with sleep – which is why our suite of NightNight products are CBN-focused.

Potential Effects:
• May improve sleep
• May act as a mild sedative

Remember This: CBN is known as the “sleep cannabinoid” and is often used to help with rest and relaxation.

CBG (Cannabigerol)

What is CBG? CBG is often called the “mother of all cannabinoids” because it is the building block for other cannabinoids like THC and CBD. CBG can be found in our Redecan Gems.

Potential Effects:
• May reduce inflammation and pain
• May help with digestive issues like IBD
• May support healthy eyes by lowering intraocular pressure (potentially helpful for diseases like glaucoma

Remember This: CBG is the “mother cannabinoid,” and it helps with inflammation and digestion.

THCv (Tetrahydrocannabivarin)

What is THCv? A cannabinoid similar to THC, but it works a little differently in your body. While THC is known for making people feel “high,” THCv may help reduce appetite and decrease inflammation.

Potential Effects:
• May reduce appetite (some call it the “diet weed”)
• May decrease signs of inflammation and inflammatory pain
• May help manage blood sugar levels

Remember This: THCv is like THC’s cousin that helps you reduce inflammation and won’t increase your appetite.

CBC (Cannabichromene)

What is CBC? CBC is a cannabinoid that doesn’t make you feel intoxicated. It’s being studied for its potential effects on inflammation and pain.

Potential Effects:
• May reduce pain and inflammation
• May support healthy brain function
• May improve mood and fight depression

Remember This: Think of CBC as the “wellness cannabinoid” that helps with pain and mood, without any psychoactive effects.

Tips to Remember the Differences

Here are some easy tips to keep these cannabinoids straight:

• CBN: Think “N” for night—it’s known for improving sleep.
• CBG: Think “G” for gut—it may help with digestion and overall wellness.
• THCv: Think “V” for variant with a vitality boost—it may trim hunger and calm inflammation.
• CBC: Think “C” for comfort—it may help with mood and inflammation.

Understanding the potential benefits of these minor cannabinoids can help you make informed choices about which products might be right for you. We believe in giving you the tools to better understand your health and wellness options. If you have any questions, don’t hesitate to ask one of our team members for more information.

This blog is for educational purposes only. Always consult with your Health Care Practitioner or contact us for more information.

Sources:
Russo, E. B. (2011). Taming THC: Potential cannabis synergy and phytocannabinoid-terpenoid entourage effects. British Journal of Pharmacology, 163(7), 1344–1364. https://doi.org/10.1111/j.1476-5381.2011.01238.x
Zou, S., & Kumar, U. (2018). Cannabinoid receptors and the endocannabinoid system: Signaling and function in the central nervous system. International Journal of Molecular Sciences, 19(3), 833. https://doi.org/10.3390/ijms19030833
McPartland, J. M., Duncan, M., Di Marzo, V., & Pertwee, R. G. (2015). Are cannabidiol and Δ9-tetrahydrocannabivarin negative modulators of the endocannabinoid system? A systematic review. British Journal of Pharmacology, 172(3), 737–753. https://doi.org/10.1111/bph.12944
Morales, P., Hurst, D. P., & Reggio, P. H. (2017). Molecular targets of the phytocannabinoids: A complex picture.
Schrot, R. J., & Hubbard, J. R. (2016). Cannabinoids: Medical implications. Annals of Medicine, 48(3), 128–141. https://doi.org/10.3109/07853890.2016.1145794
Bolognini, D., Costa, B., Maione, S., Comelli, F., Marini, P., Di Marzo, V., Parolaro, D., Ross, R.A., Gauson, L.A., Cascio, M.G. and Pertwee, R.G. (2010), The plant cannabinoid Δ9-tetrahydrocannabivarin can decrease signs of inflammation and inflammatory pain in mice. British Journal of Pharmacology, 160: 677-687. https://doi.org/10.1111/j.1476-5381.2010.00756.x
Noriko Shinjyo, Vincenzo Di Marzo, The effect of cannabichromene on adult neural stem/progenitor cells, Neurochemistry International, Volume 63, Issue 5, 2013, Pages 432-437, ISSN 0197-0186, https://doi.org/10.1016/j.neuint.2013.08.002.
Borrelli F, Fasolino I, Romano B, Capasso R, Maiello F, Coppola D, Orlando P, Battista G, Pagano E, Di Marzo V, Izzo AA. Beneficial effect of the non-psychotropic plant cannabinoid cannabigerol on experimental inflammatory bowel disease. Biochem Pharmacol. 2013 May 1;85(9):1306-16. doi: 10.1016/j.bcp.2013.01.017. Epub 2013 Feb 12. PMID: 23415610.
Nadolska K, Goś R. Mozliwości zastosowania kannabinoidów w leczeniu jaskry [Possibilities of applying cannabinoids’ in the treatment of glaucoma]. Klin Oczna. 2008;110(7-9):314-7. Polish. PMID: 19112869.
Qin N, Neeper MP, Liu Y, Hutchinson TL, Lubin ML, Flores CM. TRPV2 is activated by cannabidiol and mediates CGRP release in cultured rat dorsal root ganglion neurons. J Neurosci. 2008 Jun 11;28(24):6231-8. doi: 10.1523/JNEUROSCI.0504-08.2008. PMID: 18550765; PMCID: PMC6670541.
Tomida I, Pertwee RG, Azuara-Blanco A. Cannabinoids and glaucoma. Br J Ophthalmol. 2004 May;88(5):708-13. doi: 10.1136/bjo.2003.032250. PMID: 15090428; PMCID: PMC1772142.
Wargent, E., Zaibi, M., Silvestri, C. et al. The cannabinoid Δ9-tetrahydrocannabivarin (THCV) ameliorates insulin sensitivity in two mouse models of obesity. Nutr & Diabetes 3, e68 (2013). https://doi.org/10.1038/nutd.2013.9
El-Alfy AT, Ivey K, Robinson K, Ahmed S, Radwan M, Slade D, Khan I, ElSohly M, Ross S. Antidepressant-like effect of delta9-tetrahydrocannabinol and other cannabinoids isolated from Cannabis sativa L. Pharmacol Biochem Behav. 2010 Jun;95(4):434-42. doi: 10.1016/j.pbb.2010.03.004. Epub 2010 Mar 21. PMID: 20332000; PMCID: PMC2866040
Maione S, Piscitelli F, Gatta L, Vita D, De Petrocellis L, Palazzo E, de Novellis V, Di Marzo V. Non-psychoactive cannabinoids modulate the descending pathway of antinociception in anaesthetized rats through several mechanisms of action. Br J Pharmacol. 2011 Feb;162(3):584-96. doi: 10.1111/j.1476-5381.2010.01063.x. PMID: 20942863; PMCID: PMC3041249
Valeri A, Chiricosta L, D’Angiolini S, Pollastro F, Salamone S, Mazzon E. Cannabichromene Induces Neuronal Differentiation in NSC-34 Cells: Insights from Transcriptomic Analysis. Life (Basel). 2023 Mar 9;13(3):742. doi: 10.3390/life13030742. PMID: 36983897; PMCID: PMC10051538.
Previous Article
Edible Cannabis for Chronic Low Back Pain
Chronic low back pain is a widespread issue that often leads to individuals exploring alternative treatments for relief. According to a recent study, cannabis edibles infused with THC and CBD, like soft chews, are emerging as potential pain relief tools with positive short-term and longer–term benefits. Study Overview In a study performed at the University of Colorado, 249 participants suffering from chronic low back pain consumed cannabis edibles that contained varying levels of THC and CBD. These edibles were classified into three categories: CBD-dominant, THC-dominant, and balanced (THC + CBD). Researchers tracked these participants over two weeks, monitoring their pain, mood, and subjective experiences during a self-administered cannabis session. View the study here: Edible cannabis for chronic low back pain: associations with pain, mood, and intoxication Key Findings • Short-Term Pain Relief: A significant correlation was found between THC dosage and short-term pain relief. • Tension Relief with CBD: While THC seemed to dominate in terms of pain relief, CBD primarily helped reduce tension. • Longer-Term Effects: Over a two-week period of regular cannabis consumption, participants across all edible categories reported reductions in pain. However, those who used CBD-dominant edibles more frequently exhibited a trend toward greater pain reduction over the longer term. Conclusion The study highlights the potential of cannabis edibles, particularly those with higher THC content, for short-term pain relief in people with chronic low back pain. While THC seems to be more effective in providing immediate pain relief, CBD may offer a more sustained benefit, especially when used consistently. These findings underscore the need for further research into the therapeutic potential of orally-administered THC and CBD, particularly their combined effects, for both short-term and extended relief from chronic pain. For individuals considering cannabis edibles for back pain, it may be worth exploring products that balance both THC and CBD for a mix of immediate and longer-lasting relief. As with any treatment, consultation with a healthcare professional is recommended.
Next Article
New Study: Cannabis Use Linked to Reduced Cognitive Decline
A new study involving over 5,000 participants has shed new light on the long-term effects of cannabis use, revealing a potential link to reduced cognitive decline as individuals age. Conducted in Denmark, this research tracked 5,162 men from early adulthood to late midlife. Participants were initially assessed at an average age of 20 using the Børge Prien's Prøve intelligence test, a widely recognized measure of cognitive ability. A follow-up evaluation was conducted decades later, at an average age of 64, alongside detailed lifestyle and health data. Read the Study Here: https://pubmed.ncbi.nlm.nih.gov/39508467/ Using linear regression models, researchers explored how cannabis use impacted cognitive decline over time. Key Findings • Less Cognitive Decline in Cannabis Users: The study found that men with a history of cannabis use experienced less cognitive decline between early adulthood and late midlife compared to those who had never used cannabis. • Frequency and Age of Use Not Significant: Among cannabis users, neither the age at which they began using cannabis nor the frequency of use was linked to greater cognitive decline. • No Harmful Long-Term Effects: Contrary to concerns about the cognitive impact of cannabis, the study found no significant evidence of harm related to age-related cognitive decline in cannabis users. Implications These findings challenge common perceptions of cannabis use, particularly its long-term effects on cognitive health. The research suggests that moderate use may not pose the cognitive risks previously assumed. In fact, it may even offer protective benefits against age-related cognitive decline. Whether you're new to cannabis or a long-time patient, this research reinforces the importance of making informed choices. If you’re curious about how medical cannabis might support your wellness journey, our team is here to help. Always consult a healthcare professional before making any decisions about medical cannabis use.

Loading